ClinicalTrials.gg
Status unknownNCT03372577Updated Dec 13, 2017

Mindfulness-based Sex Therapy on Patients With Takotsubo Cardiomyopathy

An interventional study of Mindfulness-Based Sex Therapy and Treatment as usual in Takotsubo Cardiomyopathy and Sexual Dysfunction, sponsored by Qazvin University Of Medical Sciences. Status unknown at 1 site in Iran, Islamic Republic of. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-13.

Sponsored by Qazvin University Of Medical Sciences · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Takotsubo cardiomyopathy (TC) is a type of non-ischemic cardiomyopathy in which there is a sudden temporary weakening of the myocardium. . In a recent study, women report more sexual dysfunction than men after 1 year after TC. Despite that a number of studies have assessed female sexual dysfunction (FSD) for TC , there is no information regarding prevalence and associated factors on FSD in women with TC. However, in a recent study on Iranian female patients with TC, more than 77% of these patients suffered from FSD. This study is aimed to assess the effectiveness of a Mindfulness-based Sex Therapy on Patients With TC.

02

Conditions studied

  • Takotsubo Cardiomyopathy
  • Sexual Dysfunction
03

In context

Takotsubo Cardiomyopathy

63 studies on the registry are indexed under Takotsubo Cardiomyopathy; 26 are open to participants now.

This study's planned enrollment of 450 is above the median of 65 across 24 interventional studies indexed under Takotsubo Cardiomyopathy.

Browse Takotsubo Cardiomyopathy studies →

Lead sponsor

Qazvin University Of Medical Sciences is the lead sponsor of 34 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18 years old at least
  • confirmed diagnosis of TC by a cardiologist according Mayo Clinic diagnostic criteria; an acute left ventricular apical ballooning of unknown cause
  • willingness to partaking for the duration of the trial
  • a basic fluency in Persian
  • living with a partner/spouse

Exclusion criteria

Exclusion Criteria:

  • cognitive disability
  • having acute myocardial infarction
  • cerebrovascular disease
  • pheochromocytoma and viral or idiopathic myocarditis
  • , participating in another RCT
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
450 participants (estimated)

Study arms

  • Experimental
    patient and partner

    Behavioral: Mindfulness-Based Sex Therapy

  • Experimental
    patient ,partner and cardiac rehabilitation team

    Behavioral: Mindfulness-Based Sex Therapy

  • Active comparator
    Treatment as usual

    Other: Treatment as usual

Interventions

  • BehavioralMindfulness-Based Sex Therapy

    It is based on an integration of psychoeducation, sex therapy, and mindfulness-based skills. the intervention will be delivered by a group of facilitators on a group based weekly.

  • OtherTreatment as usual

    Routine discharge counseling

06

What researchers measure

Primary outcomes

  1. Sexual functioning

    Sexual functioning is assessed using self-reported measure , female Sexual Function Index (FSFI)

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  2. Sexual Distress

    Female Sexual Distress Scale;The FSDS-R is a self-reported questionnaire consisting of 13 items assessing different aspects of sexual activity-related distress in women

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  3. Intimacy

    Personal Assessment of Intimacy in Relationships (PAIR) will use to assess relationship satisfaction. The PAIR is a self-reported measure with 36 items which cover five subscales

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

Secondary outcomes

  1. Mindfulness

    Sexual Five-Facet Mindfulness Questionnaire (FFMQ-S) is used to assess mindfulness in the context of sexual encounters

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  2. Marital satisfaction

    The Maudsley Marital Questionnaire (MMQ) is a 20-item instrument measuring marital satisfaction.

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  3. Psychological distress

    Hospital Anxiety and Depression Scale (HADS) is a brief self-administrated tool to assess psychological distress in patients as well as general populations

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  4. Rumination

    Rumination is measured using Ruminative Thought Style Questionnaire (RTS). The RTS contains 20 items describing positive, negative and neutral facets of global rumination

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  5. Emotion regulation

    Persons' emotions in response to stressful life events is measured using he Cognitive Emotion Regulation Questionnaire short version (CERQ-short).

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  6. quality of life

    HRQoL is measured using Short Form health survey (SF-12).

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  7. Social Support

    Social support will be assessed by the ENRICHD Social Support Inventory (ESSI ).

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

  8. Sense of Coherence

    Sense of coherence will be measured using the Antonovsky's 13-item sense of coherence scale (SOC-13).

    Time frame: changes from baseline, 1 Months ,6 months, 12 months and 18 months

07

Study locations

1 of 1 sites recruiting
  • Booali Sina Hospital
    Qazvin, 3419759811, Iran, Islamic Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2017 (actual). Primary completion is estimated for Dec 2018, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2017
First posted
Dec 13, 2017
StartActual
Dec 1, 2017
Primary completionEst.
Dec 1, 2018
CompletionEst.
Jul 1, 2019
Last update
Dec 13, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03372577
Lead sponsor
Qazvin University Of Medical Sciences
Responsible party
Amir H Pakpour (Director of Social Determinants of Health Research Center (SDH), Qazvin University Of Medical Sciences) — Principal investigator
First posted
Dec 13, 2017
Start date
Dec 1, 2017
Primary completion
Dec 1, 2018 (estimated)
Completion
Jul 1, 2019 (estimated)
Last update
Dec 13, 2017

Study contacts

Amir Pakpour, Ph.D.
Contact
pakpour_amir@yahoo.com
+98-28-33239259

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion